REFERENCES
- Albelda S. A. Gene therapy. Paper read at First International Symposium on Malignant Mesothelioma. 2004
- Brickman L. Asbestos litigation. Paper read at Asbestos Litigation Conference: Center for Legal Policy at the Manhattan Institute. 2004
- Carroll S. J, Hensler D. R., Gross J., Sloss E. M., Schonlau M., Abrahamse J., Ashwood S. Asbestos litigation. RAND Corporation, Santa Monica, CA 2005
- Gordon G. J., Rockwell G. N., Jensen R. V., Rheinwald J. G., Glickman J. N., Aronson J. P., Pottorf B. J., Nitz M. D., Richards W. G., Sugarbaker D. J., Bueno R. Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling. Am. J. Pathol. 2005; 166(6)1827–1840, [INFOTRIEVE], [CSA]
- Leahy. 2005, (U.S. Senator, D-VT). U.S. Senate speech on the asbestos trust fund issue, July 26
- Linder C., Linder S., Munck-Wikland E., Auer G., Aspenblad U., Strander H. Evaluation of tissue and serum VEGF in patients with head and neck carcinoma. Angiogenesis 1998; 2(4)365–372, [INFOTRIEVE], [CROSSREF], [CSA]
- National Program of Cancer Registries, Data Collection and Surveillance. United States Cancer Statistics: 2001 Incidence and mortality web-based report. Centers for Disease Control and Prevention, National Cancer Institute, North American Association of Central Cancer Registries, 2001, Appendix F1
- Ong S. T., Vogelzang N. J. Chemotherapy in malignant pleural mesothelioma. A review. J. Clin. Oncol. 1996; 14(3)1007–1017, [INFOTRIEVE], [CSA]
- Pass H. I. Malignant pleural mesothelioma: Surgical roles and novel therapies. Clin. Lung Cancer 2001; 3(2)102–117, [INFOTRIEVE], [CSA]
- Roggli V. L., Sharma A., Butnor K. J., Sporn T., Vollmer R. T. Malignant mesothelioma and occupational exposure to asbestos: A clinicopathological correlation of 1445 cases. Ultrastruct. Pathol. 2002; 26(2)55–65, [INFOTRIEVE], [CROSSREF], [CSA]
- Schmitt C., Clemente F. Public Citizen. 2005; 19, Federal asbestos litigation: The winners are:. May: 4
- Specter A. The Fairness in Asbestos Injury Resolution Act of 2005. 2005, (U.S. Senator, R-PA)
- Surveillance, Epidemiology, and End Results (SEER) Program. National Cancer Institute. 2004, www.seer.cancer.gov, accessed 2006
- Vogelzang N. J. Therapeutic progress in malignant mesothelioma: Clinical advances in non-small cell lung cancer and mesothelioma. 2004, [CME course]. Medscape, August 24. www.medscape.com/viewprogram/2602, accessed April 21, 2005
- Vogelzang N. J., Rusthoven J. J., Symanowski J., Denham C., Kaukel E., Ruffie P., Gatzemeier U., Boyer M., Emri S., Manegold C., Niyikiza C., Paoletti P. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J. Clin. Oncol. 2003; 21(14)2636–2644, [INFOTRIEVE], [CROSSREF], [CSA]